Table 3.
Exposure* | ASD Cases (N= 407) n (%) |
Controls (N= 2075) n (%) |
Crude OR (95%) | ORadj ** (95% CI) |
---|---|---|---|---|
Unexposed group*** | 199 (48.9) | 1080 (52.0) | reference | reference |
Any infection | ||||
30 Days Pre Conception | 33 (8.1) | 124 (6.0) | 1.44 (0.96 – 2.18) | 1.41 (0.92 – 2.18) |
Pregnancy period1 | 198 (49.0) | 960 (46.3) | 1.12 (0.90 – 1.39) | 1.15 (0.92 – 1.43) |
1st Trimester | 75 (18.4) | 408 (19.7) | 1.00 (0.75 – 1.33) | 1.07 (0.79 – 1.45) |
2nd Trimester | 81 (19.9) | 369 (17.8) | 1.19 (0.90 – 1.58) | 1.21 (0.90 – 1.63) |
3rd Trimester | 109 (26.8) | 512 (24.7) | 1.15 (0.89 – 1.49) | 1.17 (0.90 – 1.52) |
3rd Trimester minus Delivery Day | 72 (17.7) | 326 (15.7) | 1.20 (0.89 – 1.60) | 1.16 (0.86 – 1.58) |
Maternal infections diagnosed during an inpatient hospitalization or outpatient clinic visit during pregnancy.
All ORs were adjusted for the matching variables (child sex, year of birth and hospital of birth) in addition to maternal age and race/ethnicity.
The unexposed group had no diagnosed infections during the period from 30 days before pregnancy to delivery
The pregnancy period is defined as the time between the last menstrual period date and the date of delivery.